A phase I open-label clinical trial, evaluating the therapeutic vaccine hVEGF26-104/RFASE in patients with advanced solid tumors

Category Primary study
Registry of TrialsOverview of Medical Research in the Netherlands
Year 2013
This article has no abstract
Epistemonikos ID: 52c624463279ec6f0703641e0862799058e65208
First added on: Apr 16, 2025